Abstract
Introduction: Plasmacytoma is a localized collection of malignant plasma cells. The disease can be divided into solitary plasmacytoma of the bone (SPB) and extramedullary plasmacytoma (EMP), both of which are distinct entities. An EMP, the rarer of the two, has soft tissue infiltration by clonal plasma cells without any occult or systemic myeloma. Whereas, SPB has a solitary lytic bone lesion with infiltration of monoclonal plasma cells, with absence of the same on a random marrow sampling or any evidence of systemic myeloma. Though SPB may involve any bone in the body but involvement of medial end of clavicle, though reported, is extremely rare. Case Report: Herein, we report a case of a 65yearold farmer presented with pain and swelling of the medial end of the left clavicle, which was postoperatively diagnosed to be a solitary plasmacytoma by virtue of histopathology and IHC, with no other evidence of osteopenic lesions on radiographs, a negative bone scan, absence of marrow involvement by monoclonal plasma cells, presence of Mband on serum protien electrophoresis, in the IgG region and no evidence of anemia, hypercalcemia, hyperuricemia, hypercreatininemia, nephropathy, respiratory and urinary tract infections that can suggest the presence of any systemic myeloma. Conclusion: The case of solitary plasmacytoma of the clavicle reported here is a very rare as a disease entity, and rarest because of the site of involvement. The patient was treated with surgery and radiotherapy and had excellent disease control.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.